Project Grant HT94252510925
Award Date 9/1/25
Completion Date 8/31/29
Dollars Obligated $3.6M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37232, USA
Similar Awards
- This $1,847,457.00 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research conducted by Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee. The research aims to transform healthcare for military service members, veterans, and the broader public through innovative and impactful studies across various medical domains, including cancer, neuroscience, infectious...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,317,028 Project Grant to Vanderbilt University Medical Center (VUMC) with a period of performance from June 1, 2024 to May 31, 2028. The grant, under CFDA 12.420 - Military Medical Research and Development program, will support VUMC's research into therapeutic interventions to reverse gastric precancer. As a leading academic medical center and biomedical research institution, VUMC will leverage its clinical expertise and...
- This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...
- This federal Project Grant award of $2,264,623.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee. The purpose of the grant is to conduct research on toxicant-mediated pulmonary hypertension in Southwest Asia veterans. The award has a performance period from May 1, 2025 to April 30, 2029. As a leading academic medical center, VUMC has demonstrated extensive...
- This federal Project Grant award of $1,267,303.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to Vanderbilt University Medical Center (VUMC) supports research to define chronic immune-related adverse events in melanoma survivors. The funding period extends from August 1, 2025 to July 31, 2028. As a prominent academic medical center and federal contractor, VUMC has demonstrated extensive capabilities in providing specialized medical research...
- This Project Grant award, totaling $2,399,874.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Vanderbilt University Medical Center (VUMC) for a project titled "Decoding the Inflammatory Spark and Fire: Unraveling the Molecular Basis of Post-Injury Syndrome and Mineralization Disorders". The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and...
- The Department of the Army Medical Command awarded Vanderbilt University Medical Center (VUMC) a $1,310,914 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on monitoring peripheral immunity to chemotherapy and immunotherapy in breast cancer. The 3-year award, which began on February 1, 2024, aims to advance the understanding of biomarkers and identify novel therapies for breast cancer treatment. As a leading academic medical center with...
- The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $525,000 Project Grant to Vanderbilt University Medical Center to investigate novel mechanisms of ovarian cancer initiation in the fallopian tube. The award, effective April 1, 2024 through March 31, 2026, supports biomedical research aimed at improving the health and care of military service members, veterans, and their families. As a sub-award under this grant, Vanderbilt University's...
- Vanderbilt University was awarded a $316,753 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 2021 through February 2024 to develop CRISPR gene insertion techniques for on-demand production of Tissue Inhibitor of Metalloproteinases (TIMP) in cases of post-traumatic osteoarthritis. The goal is to transform treatment for service members and the public through innovative...
- Virginia Commonwealth University was awarded a $749,446 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2023 through September 2026 to develop a novel TNF inhibitor to improve outcomes in a mouse model of traumatic brain injury. Through supporting innovative biomedical research, the Military Medical Research and Development program aims to transform military and...